FDA to Probe Incidents of Shrinking Heart Stents

by Kathy Jones on  November 21, 2011 at 8:50 PM Medical Gadgets
RSS Email Print This Page Comment
The US Food and Drug Administration has revealed that it is working closely with stent manufacturers in order to find the exact cause that makes the newer class of heart stents to shrink or lengthen on rare occasions.
 FDA to Probe Incidents of Shrinking Heart Stents
FDA to Probe Incidents of Shrinking Heart Stents
Advertisement

The FDA added that majority of such incidents have taken place in Promus and Ion devices made by Boston Scientific Corp.

Advertisement
While the Ion stent has been approved by the FDA to be marketed in the United States, Boston Scientific has submitted an application to market Promus stents as well.

In a statement made to the Reuters news agency, the FDA said, "FDA is actively working with (drug-eluting stent) manufacturers, including Boston Scientific, to better understand longitudinal stent deformation with respect to its causes, predisposing underlying anatomic conditions, operator techniques that can reduce the likelihood of its occurrence, and treatment strategies should it occur."

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Heart Healthy Heart Statins Mitral Valve Prolapse Aortic Valve Stenosis Pericarditis 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive